These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 26124051

  • 1. Elevated Pressure Enhanced Trail-Induced Apoptosis in Hepatocellular Carcinoma Cells Via Erk1/2-Inactivation.
    Hong E, Lee E, Kim J, Kwon D, Lim Y.
    Cell Mol Biol Lett; 2015 Dec; 20(4):535-48. PubMed ID: 26124051
    [Abstract] [Full Text] [Related]

  • 2. Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells.
    Im SR, Jang YJ.
    Biochem Biophys Res Commun; 2012 Jul 20; 424(1):65-70. PubMed ID: 22728039
    [Abstract] [Full Text] [Related]

  • 3. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
    Lee HH, Jeong JW, Lee JH, Kim GY, Cheong J, Jeong YK, Yoo YH, Choi YH.
    Oncol Rep; 2013 Sep 20; 30(3):1257-64. PubMed ID: 23828231
    [Abstract] [Full Text] [Related]

  • 4. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
    Koehler BC, Urbanik T, Vick B, Boger RJ, Heeger S, Galle PR, Schuchmann M, Schulze-Bergkamen H.
    World J Gastroenterol; 2009 Dec 21; 15(47):5924-35. PubMed ID: 20014456
    [Abstract] [Full Text] [Related]

  • 5. Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun/AP-1 signaling pathway.
    Jin CY, Park C, Hong SH, Han MH, Jeong JW, Xu H, Liu H, Kim GY, Kim WJ, Yoo YH, Choi YH.
    Biomed Pharmacother; 2013 May 21; 67(4):321-8. PubMed ID: 23582782
    [Abstract] [Full Text] [Related]

  • 6. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
    Kim EY, Ryu JH, Kim AK.
    Int J Oncol; 2013 Oct 21; 43(4):1291-300. PubMed ID: 23857473
    [Abstract] [Full Text] [Related]

  • 7. The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2.
    Liang X, Du J, Liu Y, Cui M, Ma C, Han L, Qu Z, Zhang Z, Sun Z, Zhang L, Chen YH, Sun W.
    Apoptosis; 2007 Oct 21; 12(10):1827-36. PubMed ID: 17701086
    [Abstract] [Full Text] [Related]

  • 8. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage.
    Park SS, Jwa E, Shin SH, Ju EJ, Park I, Pak JH, Hwang JJ, Cho DH, Kim BM, Kim SB, Lee JS, Song SY, Jeong SY, Choi EK.
    Int J Biochem Cell Biol; 2017 Feb 21; 83():47-55. PubMed ID: 27923747
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K, Okano J, Nagahara T, Murawaki Y.
    Int J Oncol; 2006 Dec 21; 29(6):1501-8. PubMed ID: 17088989
    [Abstract] [Full Text] [Related]

  • 10. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
    Jin CY, Park C, Moon SK, Kim GY, Kwon TK, Lee SJ, Kim WJ, Choi YH.
    Anticancer Drugs; 2009 Sep 21; 20(8):713-22. PubMed ID: 19617819
    [Abstract] [Full Text] [Related]

  • 11. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG, Choi YH, Hyun JW, Kim GY.
    Environ Toxicol Pharmacol; 2014 Nov 21; 38(3):959-67. PubMed ID: 25461556
    [Abstract] [Full Text] [Related]

  • 12. Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells.
    Yoon JY, Cho HS, Lee JJ, Lee HJ, Jun SY, Lee JH, Song HH, Choi S, Saloura V, Park CG, Kim CH, Kim NS.
    Mol Carcinog; 2016 Apr 21; 55(4):387-96. PubMed ID: 25647515
    [Abstract] [Full Text] [Related]

  • 13. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF, Cao JG, Tian L, Liu F.
    Cancer Chemother Pharmacol; 2012 Jan 21; 69(1):195-206. PubMed ID: 21660448
    [Abstract] [Full Text] [Related]

  • 14. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
    Wang JG, Zheng XX, Zeng GY, Zhou YJ, Yuan H.
    Oncol Rep; 2014 Jan 21; 31(1):488-96. PubMed ID: 24247909
    [Abstract] [Full Text] [Related]

  • 15. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.
    Cell Death Differ; 2004 Jul 21; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [Abstract] [Full Text] [Related]

  • 16. cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis.
    Guicciardi ME, Bronk SF, Werneburg NW, Gores GJ.
    Am J Physiol Gastrointest Liver Physiol; 2007 May 21; 292(5):G1337-46. PubMed ID: 17272514
    [Abstract] [Full Text] [Related]

  • 17. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
    Hong M, Li J, Li S, M Almutairi M.
    Cells; 2019 Nov 19; 8(11):. PubMed ID: 31752383
    [Abstract] [Full Text] [Related]

  • 18. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5.
    Kim EY, Yu JS, Yang M, Kim AK.
    Mol Cells; 2013 Jan 19; 35(1):32-40. PubMed ID: 23224239
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of ERK1/2 and CREB phosphorylation by caspase-dependent mechanism enhances apoptosis in a fibrosarcoma cell line treated with butyrate.
    Rabelo FL, Ropert C, Ramos MG, Bonjardim CA, Gazzinelli RT, Alvarez-Leite JI.
    Biochem Biophys Res Commun; 2003 Apr 11; 303(3):968-72. PubMed ID: 12670506
    [Abstract] [Full Text] [Related]

  • 20. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.